课题基金 / 基金详情

Core--clinical

Core--clinical
核心--临床
批准号:
6365595
负责人:
BERTIL E GLADER
金额:
$24.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-28 至 2005-08-31

项目摘要

项目成果

BERTIL E GLADER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of the Clinical Core is to: (1) assist in clinical trial design; (2) maintain the appropriate regulatory infrastructure and ensure compliance at the local, state, and federal levels for proposed and future clinical trials; (3) interface and data transfer to the private CRO and National PEGT data management specialists. Patients in three clinical trials will be treated at Stanford University or The Children's Hospital of Philadelphia. While record keeping will ultimately be the responsibility of the center in which the patient is treated, Stanford University will serve as the lead Center for maintaining the overall organizational framework of the trials through the Core. While the GCRC at Stanford University will serve as the physical site of the Clinical Core, participants from both institutions are represented. A description of the GCRC at Stanford and a brief summary of the GCRC at CHOP follows. The duties of the clinical core is described herein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDENTIFICATION OF PATIENTS WITH DIAMOND BLACKFAN ANEMIA
  • 批准号:
    7869642
  • 项目类别:
  • 资助金额:
    $11.92万
  • 财政年份:
    2009
  • 负责人:
    BERTIL E GLADER
  • 依托单位:
IDENTIFICATION OF PATIENTS WITH DIAMOND BLACKFAN ANEMIA
  • 批准号:
    7923752
  • 项目类别:
  • 资助金额:
    $11.92万
  • 财政年份:
    2009
  • 负责人:
    BERTIL E GLADER
  • 依托单位:
RITUXIMAB FOR CHRONIC, SEVERE IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN
  • 批准号:
    7202094
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2004
  • 负责人:
    BERTIL E GLADER
  • 依托单位:
A PHASE I SAFETY STUDY IN PATIENTS WITH SEVERE HEMOPHILIA B
  • 批准号:
    7202030
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2004
  • 负责人:
    BERTIL E GLADER
  • 依托单位:
海外基金